32.96
price up icon0.46%   0.15
after-market 시간 외 거래: 32.96
loading
전일 마감가:
$32.81
열려 있는:
$32.81
하루 거래량:
317.86K
Relative Volume:
0.52
시가총액:
$1.57B
수익:
-
순이익/손실:
$-86.97M
주가수익비율:
-13.63
EPS:
-2.4189
순현금흐름:
$-81.88M
1주 성능:
+4.11%
1개월 성능:
+17.71%
6개월 성능:
+136.27%
1년 성능:
+346.61%
1일 변동 폭
Value
$31.82
$33.50
1주일 범위
Value
$30.76
$33.80
52주 변동 폭
Value
$7.09
$44.89

Mbx Biosciences Inc Stock (MBX) Company Profile

Name
명칭
Mbx Biosciences Inc
Name
전화
(317) 989-3100
Name
주소
11711 N. MERIDIAN STREET, CARMEL
Name
직원
63
Name
트위터
Name
다음 수익 날짜
2026-03-16
Name
최신 SEC 제출 서류
Name
MBX's Discussions on Twitter

Compare MBX vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
MBX icon
MBX
Mbx Biosciences Inc
32.96 1.56B 0 -86.97M -81.88M -2.4189
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-28 개시 Barclays Overweight
2025-12-04 개시 Goldman Sell
2025-11-04 개시 TD Cowen Buy
2025-10-15 개시 Truist Buy
2025-08-15 재개 Jefferies Buy
2025-08-05 개시 Mizuho Outperform
2025-07-16 개시 Oppenheimer Outperform
2025-04-10 개시 Citizens JMP Mkt Outperform
2024-10-08 개시 Guggenheim Buy
2024-10-08 개시 JP Morgan Overweight
2024-10-08 개시 Jefferies Buy
2024-10-08 개시 Stifel Buy
모두보기

Mbx Biosciences Inc 주식(MBX)의 최신 뉴스

pulisher
Apr 13, 2026

Stifel reiterates Buy on MBX Biosciences stock, keeps $50 target - Investing.com

Apr 13, 2026
pulisher
Apr 13, 2026

Is MBX Biosciences Inc stock influenced by commodity pricesWeekly Earnings Recap & Daily Growth Stock Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Goldman Sachs initiates coverage of MBX Biosciences (MBX) with sell recommendation - MSN

Apr 12, 2026
pulisher
Apr 11, 2026

MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Apr 11, 2026
pulisher
Apr 07, 2026

MBX Biosciences, Inc. focuses on science-led innovation to transform endocrine and metabolic disease treatment - Traders Union

Apr 07, 2026
pulisher
Apr 07, 2026

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Apr 07, 2026
pulisher
Apr 07, 2026

Institution Moves: Is MBX Biosciences Inc part of any ETF2026 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 04, 2026

Does MBX (MBX) Options-Driven Breakout Reveal Deeper Shifts In Its Investment Narrative? - Yahoo Finance

Apr 04, 2026
pulisher
Apr 04, 2026

MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Apr 04, 2026
pulisher
Apr 04, 2026

MBX Biosciences (MBX) Is Up 16.6% After Analyst Initiation And Leadership Award News Has The Bull Case Changed? - Sahm

Apr 04, 2026
pulisher
Apr 03, 2026

MBX Biosciences Approves Equity-Based Inducement Grant for New Employee Under Nasdaq Rule - geneonline.com

Apr 03, 2026
pulisher
Apr 03, 2026

MBX Biosciences Reports Inducement Grant - National Today

Apr 03, 2026
pulisher
Apr 03, 2026

Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings - MarketBeat

Apr 03, 2026
pulisher
Apr 02, 2026

MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital - MarketBeat

Apr 02, 2026
pulisher
Mar 31, 2026

MBX Biosciences (NASDAQ:MBX) Shares Up 8.5%What's Next? - MarketBeat

Mar 31, 2026
pulisher
Mar 30, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest - MarketBeat

Mar 30, 2026
pulisher
Mar 29, 2026

MBX PE Ratio & Valuation, Is MBX Overvalued - Intellectia AI

Mar 29, 2026
pulisher
Mar 29, 2026

221,672 Shares in MBX Biosciences, Inc. $MBX Acquired by Goelzer Investment Management Inc. - MarketBeat

Mar 29, 2026
pulisher
Mar 26, 2026

MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know - Yahoo Finance

Mar 26, 2026
pulisher
Mar 26, 2026

Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

MBX Biosciences, Inc. (NASDAQ:MBX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 26, 2026
pulisher
Mar 25, 2026

MBX (NASDAQ: MBX) affiliate files sale notice for 1,061 vested shares - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

MBX Biosciences (MBX) Is Down 6.5% After Wider Losses And New Shelf Filings Has The Bull Case Changed? - simplywall.st

Mar 25, 2026
pulisher
Mar 23, 2026

Hudson Bay Capital Management LP Purchases New Stake in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 23, 2026
pulisher
Mar 22, 2026

Aug Intraday: Can MBX Biosciences Inc keep up with sector leaders2026 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 20, 2026

MBX Biosciences Advances Avail Phase 2 Trial in Hypoparathyroidism: What Investors Should Watch - TipRanks

Mar 20, 2026
pulisher
Mar 19, 2026

Top MBX Biosciences (MBX) Competitors 2026 - MarketBeat

Mar 19, 2026
pulisher
Mar 19, 2026

New weekly therapy moves toward Phase 3 for hypoparathyroidism - Hypoparathyroidism News

Mar 19, 2026
pulisher
Mar 18, 2026

MBX Biosciences (MBX) CFO John Smither files initial Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 17, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Mar 17, 2026
pulisher
Mar 17, 2026

MBX Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2026
pulisher
Mar 16, 2026

MBX Biosciences Chief Makes Bold Insider Move With Major Stock Buy - TipRanks

Mar 16, 2026
pulisher
Mar 16, 2026

Company (NASDAQ: MBX) Form 144 — 10,000-share sale notice via Fidelity - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (NASDAQ:MBX) Shares Gap Up After Insider Buying Activity - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

A Look At MBX Biosciences (MBX) Valuation After Recent Share Price Pullback - simplywall.st

Mar 16, 2026
pulisher
Mar 16, 2026

Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 By Investing.com - Investing.com India

Mar 16, 2026
pulisher
Mar 16, 2026

Hawryluk P. Kent buys MBX Biosciences shares worth $525,662 - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (NASDAQ:MBX) CEO Buys $525,585.00 in Stock - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Biosciences (MBX) CEO adds 18,500 shares via trust purchase - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

MBX Phase 3 Plans And New CBO Sharpen Rare Disease Focus - Yahoo Finance

Mar 16, 2026
pulisher
Mar 15, 2026

Baker BROS. Advisors LP Takes $4.86 Million Position in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

MBX Biosciences completes FDA meeting for Phase 3 trial design - Investing.com Nigeria

Mar 14, 2026
pulisher
Mar 14, 2026

Ghisallo Capital Management LLC Takes $669,000 Position in MBX Biosciences, Inc. $MBX - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High? - MSN

Mar 14, 2026
pulisher
Mar 13, 2026

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and REPRO-MED Systems (KRMD) - The Globe and Mail

Mar 13, 2026
pulisher
Mar 13, 2026

MBX Biosciences Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Citizens reiterates Market Outperform on MBX Biosciences stock - Investing.com Nigeria

Mar 13, 2026

Mbx Biosciences Inc (MBX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
자본화:     |  볼륨(24시간):